NDRC Considers Revising Drug Pricing System – Sources
This article was originally published in PharmAsia News
Executive Summary
China’s National Development and Reform Commission is looking to cancel drug retail price caps and independent pricing for off-patent drugs, and introduce identical health insurance coverage amounts for multinational and domestic drugs, according to sources.